HomeCompareORXOF vs PG

ORXOF vs PG: Dividend Comparison 2026

ORXOF yields 87.48% · PG yields 2.93%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORXOF wins by $2.25M in total portfolio value
10 years
ORXOF
ORXOF
● Live price
87.48%
Share price
$2.29
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.30M
Annual income
$708,964.09
Full ORXOF calculator →
PG
Procter & Gamble
● Live price
2.93%
Share price
$144.42
Annual div
$4.23
5Y div CAGR
31.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.5K
Annual income
$9,992.83
Full PG calculator →

Portfolio growth — ORXOF vs PG

📍 ORXOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodORXOFPG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ORXOF + PG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ORXOF pays
PG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORXOF
Annual income on $10K today (after 15% tax)
$7,435.92/yr
After 10yr DRIP, annual income (after tax)
$602,619.48/yr
PG
Annual income on $10K today (after 15% tax)
$248.80/yr
After 10yr DRIP, annual income (after tax)
$8,493.91/yr
At 15% tax rate, ORXOF beats the other by $594,125.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORXOF + PG for your $10,000?

ORXOF: 50%PG: 50%
100% PG50/50100% ORXOF
Portfolio after 10yr
$1.18M
Annual income
$359,478.46/yr
Blended yield
30.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PG right now

ORXOF
No analyst data
Altman Z
-0.2
Piotroski
3/9
PG
Analyst Ratings
29
Buy
22
Hold
1
Sell
Consensus: Buy
Price Target
$167.67
+16.1% upside vs current
Range: $150.00 — $179.00
Altman Z
5.3
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORXOF buys
0
PG buys
0
No recent congressional trades found for ORXOF or PG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricORXOFPG
Forward yield87.48%2.93%
Annual dividend / share$2.00$4.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%31.1%
Portfolio after 10y$2.30M$51.5K
Annual income after 10y$708,964.09$9,992.83
Total dividends collected$2.02M$29.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ORXOF vs PG ($10,000, DRIP)

YearORXOF PortfolioORXOF Income/yrPG PortfolioPG Income/yrGap
1← crossover$19,448$8,748.14$11,004$383.73+$8.4KORXOF
2$36,710$15,900.47$12,207$521.25+$24.5KORXOF
3$67,330$28,049.97$13,678$713.84+$53.7KORXOF
4$120,123$48,080.71$15,513$987.38+$104.6KORXOF
5$208,701$80,169.36$17,858$1,382.44+$190.8KORXOF
6$353,484$130,173.43$20,929$1,964.45+$332.6KORXOF
7$584,283$206,054.85$25,069$2,842.17+$559.2KORXOF
8$943,494$318,311.52$30,826$4,202.54+$912.7KORXOF
9$1,489,918$480,379.75$39,116$6,379.22+$1.45MORXOF
10$2,303,177$708,964.09$51,534$9,992.83+$2.25MORXOF

ORXOF vs PG: Complete Analysis 2026

ORXOFStock

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.

Full ORXOF Calculator →

PGConsumer Staples

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Full PG Calculator →
📬

Get this ORXOF vs PG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORXOF vs SCHDORXOF vs JEPIORXOF vs OORXOF vs KOORXOF vs MAINORXOF vs KMBORXOF vs CLORXOF vs CHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.